Treatment with finasteride following radical prostatectomy for prostate cancer

By Andriole G.   Lieber M.   Smith J.   Soloway M.   Schroeder F.   Kadmon D.   DeKernion J.   Rajfer J.   Boake R.   Crawford D.   Ramsey E.   Perreault J.   Trachtenberg J.   Fradet Y.   Block N.   Middleton R.   Ng J.   Ferguson D.   Gormley G.  

Urology, Vol. 45, Iss. 3, 1995-03 ,pp. : 491-497

Elsevier

Access to resources Recommend Favorite

Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate

By Krupski T.   Petroni G.R.   Frierson H.F.   Theodorescu J.o.U.U.o.V.H.S.C.C.V.U.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 743-749

Elsevier

Access to resources Recommend Favorite

Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer

By Vicini F.A.   Ziaja E.L.   Kestin L.L.   Brabbins D.S.   Stromberg J.S.   Gonzalez J.A.   Martinez A.A.  

Urology, Vol. 54, Iss. 1, 1999-07 ,pp. : 111-117

Elsevier

Access to resources Recommend Favorite

Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer

By Clark P.E.   Peereboom D.M.   Dreicer R.   Levin H.S.   Clark S.B.   Klein E.A.  

Urology, Vol. 57, Iss. 2, 2001-02 ,pp. : 281-285

Elsevier

Access to resources Recommend Favorite

Captopril may reduce biochemical (prostate-specific antigen) failure following radical prostatectomy for clinically localized prostate cancer

By Ronquist Gunnar   Frithz Goran   Wang Yu-Hui   Lindeborg Torsten  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 1, 2009-02 ,pp. : 32-36

Informa Healthcare

Access to resources Recommend Favorite